The Scarlett Fund at Memorial Sloan Kettering Cancer Center (MSK) was created by Jennifer and Robert James to support
and raise awareness for pediatric cancer research in honor of their 8 year-old daughter, Scarlett James.
Scarlett was diagnosed with T Cell Lymphoma, a rare form of pediatric cancer, at age 6. Aware of the sacrifices children and their families had made before them to make Scarlett's treatment possible, the James Family is inspired to help children that follow behind Scarlett with the hope that their treatment is less lengthy, less intense and less toxic. The money raised is being used to research novel targeted therapies which have great potential. Because these therapies target cancer cells, they reduce toxicity to healthy tissues and decrease long terms side effects. This is especially important for growing children.
Nearly 16,000 children and adolescents in the United States will be diagnosed with cancer this year. MSK is entrusted with many of these young lives, as this great health institution treats more children with cancer than any other institution in the world. Families seek care from all over the world—sometimes after exhausting options at other hospitals—to access the most effective and novel therapies. Even though the number of children diagnosed with cancer is growing each year, pediatric cancers are considered rare and receive only 4% of the US federal funds allocated to cancer research.
Gifts to The Scarlett Fund support groundbreaking pediatric precision medicine initiative at MSK. Although there have been signiﬁcant advances in the treatment of childhood cancers, the main treatment option is still chemotherapy, which can be harmful, not just to cancer cells, but also to a child’s healthy cells. The precision medicine initiative focuses on identifying genetic mutations and developing targeted therapies for children with cancer.
As exhaustive research and development enters a new era of precision medicine, it is vital that MSK continues to develop personalized treatments for children with cancer. In order to do this, MSK must also build the infrastructure needed to perform tumor sequencing and genetic testing for pediatric patients. Your support of The Scarlett Fund allows MSK to pursue these goals and bring new and more effective treatments to children with cancer across the world.
Khayyan founders were personally affected by pediatric cancer when Scarlett James, the daughter of Jennifer and Robert James the entire James family being a dear friend of ours, and Charlotte Naranjo-Griffiths, a little girl very dear to the founder of Khayyan, simultaneously found themselves lying next to each other in the same hospital room at Memorial Sloan Kettering Pediatric Cancer Center in New York.
The reality of how these two little 6 and 7 year-old little girls would meet in the winter of 2013 under such terrifying circumstances both being in our lives, separately, was truly extraordinary. Neither families nor Scarlett or Charlotte knew one another prior to this life changing experience, but both Khayyan principals knew the individual families and precious little girls seperately. Imagine that.
Well, at that moment, we imagined that through our efforts, Khayyan and Olivar SANTAMARIA®, can make a difference by developing an exquisite, organic, premium ultra-healthy extra virgin olive oil and do our part by donating a portion of all proceed to pediatric cancer research and join in the substantial contributions already made by The Scarlett Fund, the James family and numerous kind Benefactors.